يعرض 1 - 10 نتائج من 50 نتيجة بحث عن '"Rybalka, E"', وقت الاستعلام: 1.25s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المؤلفون: Campelj, DG, Timpani, CA, Rybalka, E

    العلاقة: Campelj, D. G., Timpani, C. A. & Rybalka, E. (2021). Cachectic muscle wasting in acute myeloid leukaemia: a sleeping giant with dire clinical consequences. JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 13 (1), pp.42-54. https://doi.org/10.1002/jcsm.12880Test.; http://hdl.handle.net/11343/305421Test

  2. 2
    دورية أكاديمية

    العلاقة: pii: 10.1186/s13023-021-01758-9; Kourakis, S., Timpani, C. A., Campelj, D. G., Hafner, P., Gueven, N., Fischer, D. & Rybalka, E. (2021). Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?. ORPHANET JOURNAL OF RARE DISEASES, 16 (1), https://doi.org/10.1186/s13023-021-01758-9Test.; http://hdl.handle.net/11343/281268Test

  3. 3
    دورية أكاديمية

    المؤلفون: Campelj, DG, Goodman, CA, Rybalka, E

    العلاقة: pii: cancers13143615; Campelj, D. G., Goodman, C. A. & Rybalka, E. (2021). Chemotherapy-Induced Myopathy: The Dark Side of the Cachexia Sphere. CANCERS, 13 (14), https://doi.org/10.3390/cancers13143615Test.; http://hdl.handle.net/11343/287434Test

  4. 4
    دورية أكاديمية

    العلاقة: pii: S2213-2317(20)31008-9; Kourakis, S., Timpani, C. A., de Haan, J. B., Gueven, N., Fischer, D. & Rybalka, E. (2021). Targeting Nrf2 for the treatment of Duchenne Muscular Dystrophy. REDOX BIOLOGY, 38, https://doi.org/10.1016/j.redox.2020.101803Test.; http://hdl.handle.net/11343/281855Test

  5. 5
    دورية أكاديمية

    المؤلفون: Timpani, CA, Rybalka, E

    العلاقة: pii: ph14010015; Timpani, C. A. & Rybalka, E. (2021). Calming the (Cytokine) Storm: Dimethyl Fumarate as a Therapeutic Candidate for COVID-19. PHARMACEUTICALS, 14 (1), https://doi.org/10.3390/ph14010015Test.; http://hdl.handle.net/11343/281269Test

  6. 6
    دورية أكاديمية

    المؤلفون: Gueven, N, Ravishankar, P, Eri, R, Rybalka, E

    العلاقة: pii: S2213-2317(20)31017-X; Gueven, N., Ravishankar, P., Eri, R. & Rybalka, E. (2021). Idebenone: When an antioxidant is not an antioxidant. REDOX BIOLOGY, 38, https://doi.org/10.1016/j.redox.2020.101812Test.; http://hdl.handle.net/11343/281854Test

  7. 7
    دورية أكاديمية

    العلاقة: pii: ph14050478; Campelj, D. G., Timpani, C. A., Cree, T., Petersen, A. C., Hayes, A., Goodman, C. A. & Rybalka, E. (2021). Metronomic 5-Fluorouracil Delivery Primes Skeletal Muscle for Myopathy but Does Not Cause Cachexia. PHARMACEUTICALS, 14 (5), https://doi.org/10.3390/ph14050478Test.; http://hdl.handle.net/11343/280619Test

  8. 8
    دورية أكاديمية

    العلاقة: pii: cancers12123810; Campelj, D. G., Timpani, C. A., Petersen, A. C., Hayes, A., Goodman, C. A. & Rybalka, E. (2020). The Paradoxical Effect of PARP Inhibitor BGP-15 on Irinotecan-Induced Cachexia and Skeletal Muscle Dysfunction. CANCERS, 12 (12), https://doi.org/10.3390/cancers12123810Test.; http://hdl.handle.net/11343/272319Test

  9. 9
    دورية أكاديمية

    المؤلفون: Rybalka, E, Timpani, CA

    العلاقة: Rybalka, E. & Timpani, C. A. (2020). Micro (mRNA) molecules could pack a big punch in the fight against neuromuscular disease. JOURNAL OF PHYSIOLOGY-LONDON, 599 (1), pp.5-6. https://doi.org/10.1113/JP280872Test.; http://hdl.handle.net/11343/281267Test

  10. 10
    دورية أكاديمية

    العلاقة: pii: ph13100306; Kourakis, S., Timpani, C. A., de Haan, J. B., Gueven, N., Fischer, D. & Rybalka, E. (2020). Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?. PHARMACEUTICALS, 13 (10), https://doi.org/10.3390/ph13100306Test.; http://hdl.handle.net/11343/281271Test